Cargando…

Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil

BACKGROUND: P.1 lineage (Gamma) was first described in the State of Amazonas, northern Brazil, in the end of 2020, and has emerged as a very important variant of concern (VOC) of SARS-CoV-2 worldwide. P.1 has been linked to increased infectivity, higher mortality, and immune evasion, leading to rein...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimerman, Ricardo Ariel, Ferrareze, Patrícia Aline Gröhs, Cadegiani, Flavio Adsuara, Wambier, Carlos Gustavo, Fonseca, Daniel do Nascimento, de Souza, Andrea Roberto, Goren, Andy, Rotta, Liane Nanci, Ren, Zhihua, Thompson, Claudia Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885995/
https://www.ncbi.nlm.nih.gov/pubmed/35242782
http://dx.doi.org/10.3389/fmed.2022.806611
_version_ 1784660552570634240
author Zimerman, Ricardo Ariel
Ferrareze, Patrícia Aline Gröhs
Cadegiani, Flavio Adsuara
Wambier, Carlos Gustavo
Fonseca, Daniel do Nascimento
de Souza, Andrea Roberto
Goren, Andy
Rotta, Liane Nanci
Ren, Zhihua
Thompson, Claudia Elizabeth
author_facet Zimerman, Ricardo Ariel
Ferrareze, Patrícia Aline Gröhs
Cadegiani, Flavio Adsuara
Wambier, Carlos Gustavo
Fonseca, Daniel do Nascimento
de Souza, Andrea Roberto
Goren, Andy
Rotta, Liane Nanci
Ren, Zhihua
Thompson, Claudia Elizabeth
author_sort Zimerman, Ricardo Ariel
collection PubMed
description BACKGROUND: P.1 lineage (Gamma) was first described in the State of Amazonas, northern Brazil, in the end of 2020, and has emerged as a very important variant of concern (VOC) of SARS-CoV-2 worldwide. P.1 has been linked to increased infectivity, higher mortality, and immune evasion, leading to reinfections and potentially reduced efficacy of vaccines and neutralizing antibodies. METHODS: The samples of 276 patients from the State of Amazonas were sent to a central referral laboratory for sequencing by gold standard techniques, through Illumina MiSeq platform. Both global and regional phylogenetic analyses of the successfully sequenced genomes were conducted through maximum likelihood method. Multiple alignments were obtained including previously obtained unique human SARS-CoV-2 sequences. The evolutionary histories of spike and non-structural proteins from ORF1a of northern genomes were described and their molecular evolution was analyzed for detection of positive (FUBAR, FEL, and MEME) and negative (FEL and SLAC) selective pressures. To further evaluate the possible pathways of evolution leading to the emergence of P.1, we performed specific analysis for copy-choice recombination events. A global phylogenomic analysis with subsampled P.1 and B.1.1.28 genomes was applied to evaluate the relationship among samples. RESULTS: Forty-four samples from the State of Amazonas were successfully sequenced and confirmed as P.1 (Gamma) lineage. In addition to previously described P.1 characteristic mutations, we find evidence of continuous diversification of SARS-CoV-2, as rare and previously unseen P.1 mutations were detected in spike and non-structural protein from ORF1a. No evidence of recombination was found. Several sites were demonstrated to be under positive and negative selection, with various mutations identified mostly in P.1 lineage. According to the Pango assignment, phylogenomic analyses indicate all samples as belonging to the P.1 lineage. CONCLUSION: P.1 has shown continuous evolution after its emergence. The lack of clear evidence for recombination and the positive selection demonstrated for several sites suggest that this lineage emergence resulted mainly from strong evolutionary forces and progressive accumulation of a favorable signature set of mutations.
format Online
Article
Text
id pubmed-8885995
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88859952022-03-02 Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil Zimerman, Ricardo Ariel Ferrareze, Patrícia Aline Gröhs Cadegiani, Flavio Adsuara Wambier, Carlos Gustavo Fonseca, Daniel do Nascimento de Souza, Andrea Roberto Goren, Andy Rotta, Liane Nanci Ren, Zhihua Thompson, Claudia Elizabeth Front Med (Lausanne) Medicine BACKGROUND: P.1 lineage (Gamma) was first described in the State of Amazonas, northern Brazil, in the end of 2020, and has emerged as a very important variant of concern (VOC) of SARS-CoV-2 worldwide. P.1 has been linked to increased infectivity, higher mortality, and immune evasion, leading to reinfections and potentially reduced efficacy of vaccines and neutralizing antibodies. METHODS: The samples of 276 patients from the State of Amazonas were sent to a central referral laboratory for sequencing by gold standard techniques, through Illumina MiSeq platform. Both global and regional phylogenetic analyses of the successfully sequenced genomes were conducted through maximum likelihood method. Multiple alignments were obtained including previously obtained unique human SARS-CoV-2 sequences. The evolutionary histories of spike and non-structural proteins from ORF1a of northern genomes were described and their molecular evolution was analyzed for detection of positive (FUBAR, FEL, and MEME) and negative (FEL and SLAC) selective pressures. To further evaluate the possible pathways of evolution leading to the emergence of P.1, we performed specific analysis for copy-choice recombination events. A global phylogenomic analysis with subsampled P.1 and B.1.1.28 genomes was applied to evaluate the relationship among samples. RESULTS: Forty-four samples from the State of Amazonas were successfully sequenced and confirmed as P.1 (Gamma) lineage. In addition to previously described P.1 characteristic mutations, we find evidence of continuous diversification of SARS-CoV-2, as rare and previously unseen P.1 mutations were detected in spike and non-structural protein from ORF1a. No evidence of recombination was found. Several sites were demonstrated to be under positive and negative selection, with various mutations identified mostly in P.1 lineage. According to the Pango assignment, phylogenomic analyses indicate all samples as belonging to the P.1 lineage. CONCLUSION: P.1 has shown continuous evolution after its emergence. The lack of clear evidence for recombination and the positive selection demonstrated for several sites suggest that this lineage emergence resulted mainly from strong evolutionary forces and progressive accumulation of a favorable signature set of mutations. Frontiers Media S.A. 2022-02-15 /pmc/articles/PMC8885995/ /pubmed/35242782 http://dx.doi.org/10.3389/fmed.2022.806611 Text en Copyright © 2022 Zimerman, Ferrareze, Cadegiani, Wambier, Fonseca, de Souza, Goren, Rotta, Ren and Thompson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zimerman, Ricardo Ariel
Ferrareze, Patrícia Aline Gröhs
Cadegiani, Flavio Adsuara
Wambier, Carlos Gustavo
Fonseca, Daniel do Nascimento
de Souza, Andrea Roberto
Goren, Andy
Rotta, Liane Nanci
Ren, Zhihua
Thompson, Claudia Elizabeth
Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title_full Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title_fullStr Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title_full_unstemmed Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title_short Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
title_sort comparative genomics and characterization of sars-cov-2 p.1 (gamma) variant of concern from amazonas, brazil
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885995/
https://www.ncbi.nlm.nih.gov/pubmed/35242782
http://dx.doi.org/10.3389/fmed.2022.806611
work_keys_str_mv AT zimermanricardoariel comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT ferrarezepatriciaalinegrohs comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT cadegianiflavioadsuara comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT wambiercarlosgustavo comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT fonsecadanieldonascimento comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT desouzaandrearoberto comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT gorenandy comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT rottalianenanci comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT renzhihua comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil
AT thompsonclaudiaelizabeth comparativegenomicsandcharacterizationofsarscov2p1gammavariantofconcernfromamazonasbrazil